{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:02:12Z","timestamp":1790154132803,"version":"4.0.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy (DEE) characterized by seizures and developmental delay\/regression, primarily caused by loss-of-function (LoF) variants in the\n                    <jats:italic>SCN1A<\/jats:italic>\n                    gene, which encodes the Nav1.1 sodium channel. Hyperexcitability in DS results from impaired inhibitory interneuron function. Sodium channel blockers are considered to be contraindicated particularly in the long-term treatment of patients with LoF variants in sodium channels as they may exacerbate seizures. However, we previously reported that cenobamate (CNB), an anti-seizure medication thought to be contraindicated due to its sodium channel blocking action, was effective in treating adult DS patients. These patients displayed a typical DS phenotype. Extended long-term follow-up demonstrated sustained clinical benefit of CNB treatment. To functionally characterize the previously unclassified patient-specific\n                    <jats:italic>SCN1A<\/jats:italic>\n                    variants, we conducted electrophysiological and localization studies using HEK cells expressing Nav1.1. Whole-cell patch-clamp recordings confirmed that the patient variants were LoF, ranging from markedly reduced to nearly absent peak sodium currents. Acute CNB exposure did not alter peak sodium current density under the experimental conditions used. These findings demonstrate sustained clinical benefit of CNB in adults with genetically confirmed DS carrying electrophysiologically confirmed LoF SCN1A variants and further expand the clinical experience with CNB in this patient population.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1894717","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:10:43Z","timestamp":1790151043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cenobamate in Dravet syndrome with electrophysiologically confirmed SCN1A loss-of-function variants: long-term real-world follow-up"],"prefix":"10.3389","volume":"17","author":[{"given":"Pascal","family":"Fenske","sequence":"first","affiliation":[{"name":"Department of Pediatric Neurology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Chronically Sick Children, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Institute of Cell- and Neurobiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"German Epilepsy Center for Children and Adolescents, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Section CNS Development and Neurologic Disease, German Center for Child and Adolescent Health (DZKJ)","place":["Berlin, Germany"]},{"name":"Institute of Neurophysiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astghik","family":"Abrahamyan","sequence":"additional","affiliation":[{"name":"Institute of Neurophysiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin L.","family":"Makridis","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Chronically Sick Children, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Institute of Cell- and Neurobiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"German Epilepsy Center for Children and Adolescents, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Section CNS Development and Neurologic Disease, German Center for Child and Adolescent Health (DZKJ)","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pommer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Chronically Sick Children, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Institute of Cell- and Neurobiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"German Epilepsy Center for Children and Adolescents, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Section CNS Development and Neurologic Disease, German Center for Child and Adolescent Health (DZKJ)","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Trimbuch","sequence":"additional","affiliation":[{"name":"Institute of Neurophysiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Friedo","sequence":"additional","affiliation":[{"name":"Epilepsieklinik Tabor","place":["Bernau, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kellinghaus","sequence":"additional","affiliation":[{"name":"Epilepsy Center M\u00fcnster-Osnabr\u00fcck, Klinikum Osnabr\u00fcck","place":["Osnabr\u00fcck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian-Phillipp","family":"Losch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Vivantes Humboldt-Klinikum","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Vivantes Humboldt-Klinikum","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bo\u00dfelmann","sequence":"additional","affiliation":[{"name":"Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Eberhard Karls University of T\u00fcbingen","place":["T\u00fcbingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamala","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Chronically Sick Children, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Institute of Cell- and Neurobiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"German Epilepsy Center for Children and Adolescents, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Section CNS Development and Neurologic Disease, German Center for Child and Adolescent Health (DZKJ)","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rosenmund","sequence":"additional","affiliation":[{"name":"Institute of Neurophysiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Kaindl","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Center for Chronically Sick Children, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Institute of Cell- and Neurobiology, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"German Epilepsy Center for Children and Adolescents, Charit\u00e9 \u2013 Universita\u0308tsmedizin Berlin","place":["Berlin, Germany"]},{"name":"Section CNS Development and Neurologic Disease, German Center for Child and Adolescent Health (DZKJ)","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1111\/epi.18101","article-title":"Pharmacological management of prolonged seizures in Dravet syndrome including intravenous phenytoin","volume":"65","author":"Abi Tayeh","year":"2024","journal-title":"Epilepsia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.25438","article-title":"SCN1A gain of function in early infantile encephalopathy","volume":"85","author":"Berecki","year":"2019","journal-title":"Ann. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cophys.2017.12.007","article-title":"Dravet Syndrome: a sodium channel interneuronopathy","volume":"2","author":"Catterall","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome","volume":"52","author":"Chiron","year":"2011","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/dmcn.12593","article-title":"Lamotrigine can be beneficial in patients with Dravet syndrome","volume":"57","author":"Dalic","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/epi.14191","article-title":"Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes","volume":"59","author":"de Lange","year":"2018","journal-title":"Epilepsia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejpn.2012.04.006","article-title":"Dravet syndrome: the main issues","volume":"16","author":"Guerrini","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1528-1157.1998.tb01413.x","article-title":"Lamotrigine and seizure aggravation in severe myoclonic epilepsy epilepsia","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/WNL.0000000000012744","article-title":"Monogenic epilepsies: disease mechanisms","volume":"97","author":"Guerrini","year":"2021","journal-title":"Clin. Phenotypes, Target. Ther. Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2023.09.006","article-title":"Real-world experience with cenobamate: a systematic review and meta-analysis","volume":"112","author":"Makridis","year":"2023","journal-title":"Seizure"},{"key":"B12","doi-asserted-by":"publisher","first-page":"950171","DOI":"10.3389\/fneur.2022.950171","article-title":"Real-world experience treating pediatric epilepsy patients with cenobamate","volume":"13","author":"Makridis","year":"","journal-title":"Front. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1111\/epi.17427","article-title":"Successful treatment of adult Dravet syndrome patients with cenobamate","volume":"63","author":"Makridis","year":"","journal-title":"Epilepsia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejphar.2019.05.007","article-title":"Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons","volume":"855","author":"Nakamura","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy","volume":"9","author":"Yu","year":"2006","journal-title":"Infancy Nat. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/acn3.51684","article-title":"Does long-term phenytoin have a place in Dravet syndrome?","volume":"9","author":"Zographos","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1894717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:10:43Z","timestamp":1790151043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1894717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":16,"alternative-id":["10.3389\/fphar.2026.1894717"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1894717","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1894717"}}